Iodine is an essential trace mineral that is the fundamental substrate for the synthesis of the thyroid hormones thyroxine (T4) and triiodothyronine (T3) — hormones that regulate metabolic rate, body temperature, heart rate, cognitive function, and the development and function of virtually every organ system in the body. The thyroid gland is the only organ in the body that actively concentrates iodine — it expresses the sodium-iodide symporter (NIS) on the basolateral membrane of thyroid follicular cells, which actively pumps iodide from the bloodstream into the thyroid gland against a concentration gradient of approximately 20-50 fold. This iodine concentration mechanism is the foundation of thyroid hormone synthesis and explains why iodine deficiency produces a characteristic pattern of thyroid dysfunction that ranges from goitre (enlargement of the thyroid gland as it attempts to capture more iodine from a low-iodine diet) to hypothyroidism, cognitive impairment, and in severe cases, cretinism in children born to iodine-deficient mothers.
Thyroid Hormone Synthesis
Thyroid hormone synthesis is a complex, multi-step process that occurs in the thyroid follicular lumen and that requires the coordinated function of multiple enzymes and transport proteins. The process begins with the active uptake of iodide from the bloodstream into thyroid follicular cells via the NIS symporter (driven by the sodium gradient generated by the Na+/K+-ATPase). The iodide is then transported across the apical membrane into the follicular lumen by the pendrin transporter. In the lumen, iodide is oxidised by thyroid peroxidase (TPO, a molybdenum-dependent heme enzyme) and then covalently bound to the tyrosine residues of thyroglobulin (the major protein of the thyroid gland) in a process called iodination. The iodinated tyrosine residues (monoiodotyrosine, MIT, and diiodotyrosine, DIT) are then coupled by TPO to form the thyroid hormones: T4 is formed by the coupling of two DIT molecules, and T3 is formed by the coupling of one MIT and one DIT molecule.
The thyroid gland stores iodinated thyroglobulin in the follicular lumen as a colloid, providing a reservoir of thyroid hormone that can be rapidly mobilised in response to TSH (thyroid-stimulating hormone) signalling from the pituitary gland. When TSH binds to its receptor on thyroid follicular cells, it stimulates the endocytosis of colloid, the proteolysis of thyroglobulin in the lysosome, and the release of free T4 and T3 into the bloodstream. The T4 and T3 then travel in the plasma bound to thyroid hormone-binding globulin (TBG), transthyretin, and albumin, which maintain a stable plasma reservoir of thyroid hormone and prevent the rapid renal clearance that would occur with free thyroid hormones. The regulation of thyroid hormone synthesis and release is under the direct control of the hypothalamus-pituitary-thyroid (HPT) axis — the hypothalamus secretes TRH (thyrotropin-releasing hormone), which stimulates the pituitary to secrete TSH, which stimulates the thyroid to synthesise and release thyroid hormones.
Iodine Deficiency and Goitre
Iodine deficiency remains one of the most common nutritional deficiency diseases in the world, affecting approximately 1.5 billion people globally (particularly in mountainous regions where iodine has been leached from the soil over geological time, and in landlocked countries where seafood is less available). The progression of iodine deficiency follows a predictable pattern. In mild iodine deficiency, the thyroid gland enlarges (goitre) in an attempt to concentrate more iodine from the bloodstream, and thyroid hormone levels remain normal. In moderate iodine deficiency, T4 levels fall (as the gland cannot produce adequate amounts of thyroid hormone), TSH rises (in response to the low T4), and the symptoms of hypothyroidism appear (fatigue, weight gain, cold intolerance, constipation, dry skin, cognitive impairment). In severe iodine deficiency (particularly in the offspring of iodine-deficient mothers during pregnancy), the neurological consequences are devastating: cretinism (irreversible intellectual disability, deafness, and motor impairment), congenital hypothyroidism, and in less severe cases, reduced IQ and cognitive function in children.
Clinical Evidence
The clinical evidence for iodine supplementation in iodine-deficient populations is compelling. A meta-analysis of controlled trials in iodine-deficient populations found that iodine supplementation significantly reduced the incidence of goitre and improved thyroid hormone levels, with the greatest benefits in school-age children and in women of reproductive age. The WHO recommends universal salt iodisation (USI) as the primary public health strategy for the prevention of iodine deficiency disorders, and the addition of iodine to salt has been one of the most successful public health nutrition interventions in history — reducing the global prevalence of iodine deficiency disorders by approximately 50% since its introduction in the 1990s. For individuals with iodine deficiency, the evidence-based dose is 150-300mcg of iodine daily from potassium iodide or kelp (which contains iodine bound to alginate fibers). The tolerable upper intake level (UL) for iodine is 1,100mcg daily for adults — concentrations above this can produce iodine-induced hyperthyroidism (the Jod-Basedow phenomenon) in people with pre-existing thyroid nodules, and can worsen autoimmune thyroiditis (Hashimoto disease and Graves disease) in susceptible individuals.
Practical Application
For general iodine status support, the evidence-based dose is 150-300mcg of iodine daily from potassium iodide (KI) or from kelp and other sea vegetables (which provide iodine in a naturally protein-bound form that is more slowly absorbed and less likely to produce transient spikes in plasma iodide). The RDA for iodine is 150mcg daily for adults, and most people in developed countries obtain adequate iodine from iodised salt, dairy products (which contain iodine from milk pipeline sanitisers), and seafood. The primary clinical indications for iodine supplementation are iodine deficiency (diagnosed by low urinary iodine concentration or by elevated TSH with normal T4), goitre, and pregnancy (when the fetal thyroid begins to function at approximately 12 weeks gestation and requires maternal iodine for thyroid hormone synthesis). For comprehensive thyroid support, iodine pairs well with selenium (for the deiodinase enzymes that convert T4 to T3), tyrosine (the amino acid precursor of thyroid hormone synthesis), and zinc (which is required for TSH secretion from the pituitary and for the function of the NIS symporter on thyroid follicular cells).
Leave a Reply